This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Art Krieg, MD
CEO at Zola Therapeutics
Speaker

Agenda Sessions

  • Activating Anti-tumor Immunity with RNA/DNA Hybrid Agonists of TLR7/8/9

    , 4:15pm
    View Session

At this event

Prev
Next
Andreas Kuhn, PhD
Senior Vice President RNA Biochemistry & CMC Development
BioNTech SE

See Art at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now